Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11287353rdf:typepubmed:Citationlld:pubmed
pubmed-article:11287353lifeskim:mentionsumls-concept:C0020459lld:lifeskim
pubmed-article:11287353lifeskim:mentionsumls-concept:C1157202lld:lifeskim
pubmed-article:11287353lifeskim:mentionsumls-concept:C2265087lld:lifeskim
pubmed-article:11287353lifeskim:mentionsumls-concept:C0205463lld:lifeskim
pubmed-article:11287353pubmed:issue5lld:pubmed
pubmed-article:11287353pubmed:dateCreated2001-4-5lld:pubmed
pubmed-article:11287353pubmed:abstractTextAlthough chronic hyperinsulinemia has been shown to induce insulin resistance, the basic cellular mechanisms responsible for this phenomenon are unknown. The present study was performed 1) to determine the time-related effect of physiological hyperinsulinemia on glycogen synthase (GS) activity, hexokinase II (HKII) activity and mRNA content, and GLUT-4 protein in muscle from healthy subjects, and 2) to relate hyperinsulinemia-induced alterations in these parameters to changes in glucose metabolism in vivo. Twenty healthy subjects had a 240-min euglycemic insulin clamp study with muscle biopsies and then received a low-dose insulin infusion for 24 (n = 6) or 72 h (n = 14) (plasma insulin concentration = 121 +/- 9 or 143 +/- 25 pmol/l, respectively). During the baseline insulin clamp, GS fractional velocity (0.075 +/- 0.008 to 0.229 +/- 0.02, P < 0.01), HKII mRNA content (0.179 +/- 0.034 to 0.354 +/- 0.087, P < 0.05), and HKII activity (2.41 +/- 0.63 to 3.35 +/- 0.54 pmol x min(-1) x ng(-1), P < 0.05), as well as whole body glucose disposal and nonoxidative glucose disposal, increased. During the insulin clamp performed after 24 and 72 h of sustained physiological hyperinsulinemia, the ability of insulin to increase muscle GS fractional velocity, total body glucose disposal, and nonoxidative glucose disposal was impaired (all P < 0.01), whereas the effect of insulin on muscle HKII mRNA, HKII activity, GLUT-4 protein content, and whole body rates of glucose oxidation and glycolysis remained unchanged. Muscle glycogen concentration did not change [116 +/- 28 vs. 126 +/- 29 micromol/kg muscle, P = nonsignificant (NS)] and was not correlated with the change in nonoxidative glucose disposal (r = 0.074, P = NS). In summary, modest chronic hyperinsulinemia may contribute directly (independent of change in muscle glycogen concentration) to the development of insulin resistance by its impact on the GS pathway.lld:pubmed
pubmed-article:11287353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:languageenglld:pubmed
pubmed-article:11287353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:citationSubsetIMlld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11287353pubmed:statusMEDLINElld:pubmed
pubmed-article:11287353pubmed:monthMaylld:pubmed
pubmed-article:11287353pubmed:issn0193-1849lld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:MatsudaMMlld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:DeFronzoR ARAlld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:KumarVVlld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:VogtCClld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:PijlHHlld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:MandarinoL...lld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:PipekRRlld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:IozzoPPlld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:Pratipanawatr...lld:pubmed
pubmed-article:11287353pubmed:authorpubmed-author:CusiK JKJlld:pubmed
pubmed-article:11287353pubmed:issnTypePrintlld:pubmed
pubmed-article:11287353pubmed:volume280lld:pubmed
pubmed-article:11287353pubmed:ownerNLMlld:pubmed
pubmed-article:11287353pubmed:authorsCompleteYlld:pubmed
pubmed-article:11287353pubmed:paginationE712-9lld:pubmed
pubmed-article:11287353pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:meshHeadingpubmed-meshheading:11287353...lld:pubmed
pubmed-article:11287353pubmed:year2001lld:pubmed
pubmed-article:11287353pubmed:articleTitlePhysiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.lld:pubmed
pubmed-article:11287353pubmed:affiliationDivision of Diabetes, Department of Medicine, The University of Texas Health Science Center, San Antonio, Texas 78284, USA.lld:pubmed
pubmed-article:11287353pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11287353pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11287353pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11287353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11287353lld:pubmed